Sign Out
Pregnancy: Etoposide can have genotoxic effects and impair the development of embryos. Etoposide has been shown to be teratogenic in animals, and has mutagenic properties. Etoposide should not be given to patients who are pregnant. If it is considered clinically essential to treat a pregnant patient she should be informed about the risk of damage to the foetus connected with the treatment. Women of child-bearing potential should avoid pregnancy during treatment with Etoposide.
Lactation: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Sedol (Etoposide). A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
